Alpha-1 Proteinase Inhibitor Deficiency Medications

Drugs associated with Alpha-1 Proteinase Inhibitor Deficiency

The following drugs and medications are in some way related to, or used in the treatment of Alpha-1 Proteinase Inhibitor Deficiency. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Drug List:

Aralast

Aralast-Np

Glassia

Prolastin

Prolastin-C

Zemaira

Orocal

Orocal may be available in the countries listed below.

Ingredient matches for Orocal

Calcium Carbonate

Calcium Carbonate is reported as an ingredient of Orocal in the following countries:

• Monaco


• Tunisia

International Drug Name Search

Oxyplastin

Oxyplastin may be available in the countries listed below.

Ingredient matches for Oxyplastin

Zinc Oxide

Zinc Oxide is reported as an ingredient of Oxyplastin in the following countries:

• Switzerland

International Drug Name Search

BiDil

BiDil is a brand name of hydralazine/isosorbide dinitrate, approved by the FDA in the following formulation(s):

BIDIL (hydralazine hydrochloride; isosorbide dinitrate - tablet; oral)

• 
  Manufacturer: ARBOR PHARMS INC
  
  Approval date: June 23, 2005
  
  Strength(s): 37.5MG;20MG ^[RLD]

Has a generic version of BiDil been approved?

No. There is currently no therapeutically equivalent version of BiDil available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of BiDil. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Methods of treating and preventing congestive heart failure with hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate
  Patent 6,465,463
  Issued: October 15, 2002
  Inventor(s): Jay N.; Cohn & Peter; Carson
  Assignee(s): NitroMed, Inc.
  The present invention provides methods or treating and preventing mortality associated with heart failure in an African American patient with hypertension and improving oxygen consumption, quality of life and exercise tolerance by administering a therapeutically effective amount of at least one hydralazine compound and at least one of isosorbide dinitrate and isosorbide mononitrate, and, optionally, one or more compounds, such as, for example, a digitalis, a diuretic compound, or a compound used to treat cardiovascular diseases. In the present invention, the hydralazine compound is preferably hydralazine or a pharmaceutically acceptable salt thereof. Preferred methods of the invention comprise administering hydralazine or a pharmaceutically acceptable salt thereof and isosorbide dinitrate.
  
  Patent expiration dates:
  
  
  • September 8, 2020
    
    ✓ 
    Patent use: METHOD OF TREATMENT OF HEART FAILURE
  
  



• 
  Methods using hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate
  Patent 6,784,177
  Issued: August 31, 2004
  Inventor(s): Jay N.; Cohn & Peter; Carson
  Assignee(s): Nitro Med, Inc.
  The present invention provides methods of treating and preventing mortality associated with heart failure in an African American patient with hypertension, and improving oxygen consumption, quality of life and exercise tolerance by administering a therapeutically effective amount of at least one hydralazine compound and at least one of isosorbide dinitrate and isosorbide mononitrate, and, optionally, one or more compounds, such as, for example, a digitalis, a diuretic compound, or a compound used to treat cardiovascular diseases. In the present invention, the hydralazine compound is preferably hydralazine or a pharmaceutically acceptable salt thereof. Preferred methods of the invention comprise administering hydralazine or a pharmaceutically acceptable salt thereof and isosorbide dinitrate.
  
  Patent expiration dates:
  
  
  • September 8, 2020
    
    ✓ 
    Patent use: METHOD OF TREATMENT OF HEART FAILURE
  
  

See also...

• BiDil Consumer Information (Drugs.com)
• BiDil Consumer Information (Wolters Kluwer)
• BiDil Consumer Information (Cerner Multum)
• Isosorbide Dinitrate/Hydralazine Consumer Information (Wolters Kluwer)
• Hydralazine and isosorbide dinitrate Consumer Information (Cerner Multum)

Ophthalmo-Septonex

Ophthalmo-Septonex may be available in the countries listed below.

Ingredient matches for Ophthalmo-Septonex

Carbaethopendecine Bromide

Carbaethopendecine Bromide is reported as an ingredient of Ophthalmo-Septonex in the following countries:

• Slovakia

International Drug Name Search

Ulcizone

Ulcizone may be available in the countries listed below.

Ingredient matches for Ulcizone

Omeprazole

Omeprazole is reported as an ingredient of Ulcizone in the following countries:

• Venezuela

International Drug Name Search

Verminal

Verminal may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Verminal

Pyrantel

Pyrantel embonate (a derivative of Pyrantel) is reported as an ingredient of Verminal in the following countries:

• Germany

International Drug Name Search

Spazmol

Spazmol may be available in the countries listed below.

Ingredient matches for Spazmol

Scopolamine

Scopolamine butylbromide (a derivative of Scopolamine) is reported as an ingredient of Spazmol in the following countries:

• Turkey

International Drug Name Search

Sicazine

Sicazine may be available in the countries listed below.

Ingredient matches for Sicazine

Sulfadiazine

Sulfadiazine silver (a derivative of Sulfadiazine) is reported as an ingredient of Sicazine in the following countries:

• France


• Portugal

International Drug Name Search

Diclofenaco potásico

Diclofenaco potásico may be available in the countries listed below.

Ingredient matches for Diclofenaco potásico

Diclofenac

Diclofenac potassium salt (a derivative of Diclofenac) is reported as an ingredient of Diclofenaco potásico in the following countries:

• Venezuela

International Drug Name Search

Serevent Inhaler

Serevent Inhaler may be available in the countries listed below.

Ingredient matches for Serevent Inhaler

Salmeterol

Salmeterol xinafoate (a derivative of Salmeterol) is reported as an ingredient of Serevent Inhaler in the following countries:

• New Zealand

International Drug Name Search

Dexamethasondinatriumfosfaat CF

Dexamethasondinatriumfosfaat CF may be available in the countries listed below.

Ingredient matches for Dexamethasondinatriumfosfaat CF

Dexamethasone

Dexamethasone 21-(disodium phosphate) (a derivative of Dexamethasone) is reported as an ingredient of Dexamethasondinatriumfosfaat CF in the following countries:

• Netherlands

International Drug Name Search

Vancotenk

Vancotenk may be available in the countries listed below.

Ingredient matches for Vancotenk

Vancomycin

Vancomycin hydrochloride (a derivative of Vancomycin) is reported as an ingredient of Vancotenk in the following countries:

• Argentina

International Drug Name Search

Stanozolol

In some countries, this medicine may only be approved for veterinary use.

In the US, Stanozolol (stanozolol systemic) is a member of the drug class androgens and anabolic steroids and is used to treat Angioedema.

US matches:

• Stanozolol

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A14AA02

CAS registry number (Chemical Abstracts Service)

0010418-03-8

Chemical Formula

C21-H32-N2-O

Molecular Weight

328

Therapeutic Categories

Anabolic

Androgen

Chemical Name

2'H-Androst-2-eno[3,2-c]pyrazol-17-ol, 17-methyl-, (5α,17ß)-

Foreign Names

• Stanozololum (Latin)
• Stanozolol (German)
• Stanozolol (French)
• Estanozolol (Spanish)

Generic Names

• Stanozolol (OS: USAN, JAN, DCF, BAN)
• Stanozololo (OS: DCIT)
• Androstanazole (IS)
• Stanazol (IS)
• Stanazolol (IS)
• Stanozolol (PH: BP 2010, USP 32, Ph. Eur. 6)
• Stanozololum (PH: Ph. Eur. 6)

Brand Names

• Menabol
  CFL, India



• Neurabol Caps.
  Cadila Gehört zu Zydus, India



• Stanabolic (veterinary use)
  Ilium Veterinary Products, Australia



• Stanazol (veterinary use)
  RWR Veterinary Products, Australia; Vetpharm, New Zealand



• Stargate (veterinary use)
  Acme, Italy



• Winstrol V (veterinary use)
  Pharmacia & Upjohn vet, United States



• Winstrol
  Desma, Spain; Sanofi-Aventis, Bahrain; Sanofi-Aventis, Egypt; Sanofi-Aventis, Kuwait; Sanofi-Aventis, Lebanon; Sanofi-Aventis, Qatar; Sanofi-Aventis, Saudi Arabia; Sanofi-Synthelabo, United Arab Emirates; Sanofi-Synthelabo, Cyprus; Sanofi-Synthelabo, Jordan

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Vessel

Vessel may be available in the countries listed below.

Ingredient matches for Vessel

Cinnarizine

Cinnarizine is reported as an ingredient of Vessel in the following countries:

• Brazil

Sulodexide

Sulodexide is reported as an ingredient of Vessel in the following countries:

• Czech Republic


• Italy


• Malaysia


• Poland


• Slovakia

International Drug Name Search

Sancef

Sancef may be available in the countries listed below.

Ingredient matches for Sancef

Ceftriaxone

Ceftriaxone disodium salt (a derivative of Ceftriaxone) is reported as an ingredient of Sancef in the following countries:

• Myanmar

International Drug Name Search

Sore Throat

Ingredient matches for Sore Throat

Phenol

Phenol is reported as an ingredient of Sore Throat in the following countries:

• United States

International Drug Name Search

Dexatat

Dexatat may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Dexatat

Dexamethasone

Dexamethasone 21-(disodium phosphate) (a derivative of Dexamethasone) is reported as an ingredient of Dexatat in the following countries:

• Austria


• Switzerland

International Drug Name Search

Setaloft

Setaloft may be available in the countries listed below.

Ingredient matches for Setaloft

Sertraline

Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Setaloft in the following countries:

• Poland

International Drug Name Search

Sertralina Tecnigen

Sertralina Tecnigen may be available in the countries listed below.

Ingredient matches for Sertralina Tecnigen

Sertraline

Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Sertralina Tecnigen in the following countries:

• Spain

International Drug Name Search